Analysis of origin and protein-protein interaction maps suggests a distinct oncogenic role of nuclear EGFR during cancer evolution

Ainur Sharip, Diyora Abdukhakimova, Xiao Wang, Alexey Kim, Yevgeniy Kim, Aigul Sharip, Askarbek Orakov, Lixia Miao, Qinglei Sun, Yue Chen, Zhenbang Chen, Yingqiu Xie

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Receptor tyrosine kinase EGFR is usually localized on plasma membrane inducing the progression of many cancers including malignancy in children (Bodey et al. In Vivo. 2005, 19:931-41), but it contains a nuclear localization signal (NLS) that mediates EGFR nuclear translocation (Lin et al. Nat Cell Biol. 2001, 3:802-8). In this report, we claim that NLS of EGFR has an old evolutionary origin. In particular, our analysis of protein-protein interaction maps reveals that nuclear EGFR (nEGFR) pathways are different from that of membrane EGFR and EGF is not found in nEGFR network, while androgen receptor (AR) is found, which suggests the evolution of prostate cancer, a well-known AR driven cancer, through changes in androgen- or EGF-dependence. Database analysis shows that nEGFR correlates with the tumor grades especially in prostate cancer patients. Structural prediction analysis indicates that NLS can compromise the differential protein binding to EGFR through stretch linkers with evolutionary mutation from N to V. In the experiment, elevation of nEGFR but not membrane EGFR was found in castration resistant prostate cancer cells. Finally, systems analysis of NLS and transmembrane domain (TM) suggests that NLS has an old origin while NLS neighboring domain of TM has undergone accelerated evolution. Thus, nEGFR has an old origin resembling the cancer evolution, but TM may interfere NLS driven signaling for natural selection of survival to evade NLS induced aggressive cancers. Our data support NLS is a dynamic inducer of EGFR oncogenesis during evolution for advanced cancers. Our model provides a novel insight into the evolutionary role of NLS in oncogenic kinases in cancers.

Original languageEnglish
Article number961
Pages (from-to)903-912
Number of pages10
JournalJournal of Cancer
Volume8
Issue number5
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Protein Interaction Maps
Nuclear Localization Signals
Neoplasms
Prostatic Neoplasms
Androgen Receptors
Epidermal Growth Factor
Membranes
Genetic Selection
Castration
Receptor Protein-Tyrosine Kinases
Systems Analysis
Protein Binding
Androgens
Carcinogenesis
Phosphotransferases
Cell Membrane
Databases

Keywords

  • EGFR
  • NLS
  • Prostate cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Analysis of origin and protein-protein interaction maps suggests a distinct oncogenic role of nuclear EGFR during cancer evolution. / Sharip, Ainur; Abdukhakimova, Diyora; Wang, Xiao; Kim, Alexey; Kim, Yevgeniy; Sharip, Aigul; Orakov, Askarbek; Miao, Lixia; Sun, Qinglei; Chen, Yue; Chen, Zhenbang; Xie, Yingqiu.

In: Journal of Cancer, Vol. 8, No. 5, 961, 01.01.2017, p. 903-912.

Research output: Contribution to journalArticle

Sharip, A, Abdukhakimova, D, Wang, X, Kim, A, Kim, Y, Sharip, A, Orakov, A, Miao, L, Sun, Q, Chen, Y, Chen, Z & Xie, Y 2017, 'Analysis of origin and protein-protein interaction maps suggests a distinct oncogenic role of nuclear EGFR during cancer evolution', Journal of Cancer, vol. 8, no. 5, 961, pp. 903-912. https://doi.org/10.7150/jca.17961
Sharip, Ainur ; Abdukhakimova, Diyora ; Wang, Xiao ; Kim, Alexey ; Kim, Yevgeniy ; Sharip, Aigul ; Orakov, Askarbek ; Miao, Lixia ; Sun, Qinglei ; Chen, Yue ; Chen, Zhenbang ; Xie, Yingqiu. / Analysis of origin and protein-protein interaction maps suggests a distinct oncogenic role of nuclear EGFR during cancer evolution. In: Journal of Cancer. 2017 ; Vol. 8, No. 5. pp. 903-912.
@article{da5d9adbb15b41d3ac768a34ca3c486b,
title = "Analysis of origin and protein-protein interaction maps suggests a distinct oncogenic role of nuclear EGFR during cancer evolution",
abstract = "Receptor tyrosine kinase EGFR is usually localized on plasma membrane inducing the progression of many cancers including malignancy in children (Bodey et al. In Vivo. 2005, 19:931-41), but it contains a nuclear localization signal (NLS) that mediates EGFR nuclear translocation (Lin et al. Nat Cell Biol. 2001, 3:802-8). In this report, we claim that NLS of EGFR has an old evolutionary origin. In particular, our analysis of protein-protein interaction maps reveals that nuclear EGFR (nEGFR) pathways are different from that of membrane EGFR and EGF is not found in nEGFR network, while androgen receptor (AR) is found, which suggests the evolution of prostate cancer, a well-known AR driven cancer, through changes in androgen- or EGF-dependence. Database analysis shows that nEGFR correlates with the tumor grades especially in prostate cancer patients. Structural prediction analysis indicates that NLS can compromise the differential protein binding to EGFR through stretch linkers with evolutionary mutation from N to V. In the experiment, elevation of nEGFR but not membrane EGFR was found in castration resistant prostate cancer cells. Finally, systems analysis of NLS and transmembrane domain (TM) suggests that NLS has an old origin while NLS neighboring domain of TM has undergone accelerated evolution. Thus, nEGFR has an old origin resembling the cancer evolution, but TM may interfere NLS driven signaling for natural selection of survival to evade NLS induced aggressive cancers. Our data support NLS is a dynamic inducer of EGFR oncogenesis during evolution for advanced cancers. Our model provides a novel insight into the evolutionary role of NLS in oncogenic kinases in cancers.",
keywords = "EGFR, NLS, Prostate cancer",
author = "Ainur Sharip and Diyora Abdukhakimova and Xiao Wang and Alexey Kim and Yevgeniy Kim and Aigul Sharip and Askarbek Orakov and Lixia Miao and Qinglei Sun and Yue Chen and Zhenbang Chen and Yingqiu Xie",
year = "2017",
month = "1",
day = "1",
doi = "10.7150/jca.17961",
language = "English",
volume = "8",
pages = "903--912",
journal = "Journal of Cancer",
issn = "1837-9664",
publisher = "Ivyspring International Publisher",
number = "5",

}

TY - JOUR

T1 - Analysis of origin and protein-protein interaction maps suggests a distinct oncogenic role of nuclear EGFR during cancer evolution

AU - Sharip, Ainur

AU - Abdukhakimova, Diyora

AU - Wang, Xiao

AU - Kim, Alexey

AU - Kim, Yevgeniy

AU - Sharip, Aigul

AU - Orakov, Askarbek

AU - Miao, Lixia

AU - Sun, Qinglei

AU - Chen, Yue

AU - Chen, Zhenbang

AU - Xie, Yingqiu

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Receptor tyrosine kinase EGFR is usually localized on plasma membrane inducing the progression of many cancers including malignancy in children (Bodey et al. In Vivo. 2005, 19:931-41), but it contains a nuclear localization signal (NLS) that mediates EGFR nuclear translocation (Lin et al. Nat Cell Biol. 2001, 3:802-8). In this report, we claim that NLS of EGFR has an old evolutionary origin. In particular, our analysis of protein-protein interaction maps reveals that nuclear EGFR (nEGFR) pathways are different from that of membrane EGFR and EGF is not found in nEGFR network, while androgen receptor (AR) is found, which suggests the evolution of prostate cancer, a well-known AR driven cancer, through changes in androgen- or EGF-dependence. Database analysis shows that nEGFR correlates with the tumor grades especially in prostate cancer patients. Structural prediction analysis indicates that NLS can compromise the differential protein binding to EGFR through stretch linkers with evolutionary mutation from N to V. In the experiment, elevation of nEGFR but not membrane EGFR was found in castration resistant prostate cancer cells. Finally, systems analysis of NLS and transmembrane domain (TM) suggests that NLS has an old origin while NLS neighboring domain of TM has undergone accelerated evolution. Thus, nEGFR has an old origin resembling the cancer evolution, but TM may interfere NLS driven signaling for natural selection of survival to evade NLS induced aggressive cancers. Our data support NLS is a dynamic inducer of EGFR oncogenesis during evolution for advanced cancers. Our model provides a novel insight into the evolutionary role of NLS in oncogenic kinases in cancers.

AB - Receptor tyrosine kinase EGFR is usually localized on plasma membrane inducing the progression of many cancers including malignancy in children (Bodey et al. In Vivo. 2005, 19:931-41), but it contains a nuclear localization signal (NLS) that mediates EGFR nuclear translocation (Lin et al. Nat Cell Biol. 2001, 3:802-8). In this report, we claim that NLS of EGFR has an old evolutionary origin. In particular, our analysis of protein-protein interaction maps reveals that nuclear EGFR (nEGFR) pathways are different from that of membrane EGFR and EGF is not found in nEGFR network, while androgen receptor (AR) is found, which suggests the evolution of prostate cancer, a well-known AR driven cancer, through changes in androgen- or EGF-dependence. Database analysis shows that nEGFR correlates with the tumor grades especially in prostate cancer patients. Structural prediction analysis indicates that NLS can compromise the differential protein binding to EGFR through stretch linkers with evolutionary mutation from N to V. In the experiment, elevation of nEGFR but not membrane EGFR was found in castration resistant prostate cancer cells. Finally, systems analysis of NLS and transmembrane domain (TM) suggests that NLS has an old origin while NLS neighboring domain of TM has undergone accelerated evolution. Thus, nEGFR has an old origin resembling the cancer evolution, but TM may interfere NLS driven signaling for natural selection of survival to evade NLS induced aggressive cancers. Our data support NLS is a dynamic inducer of EGFR oncogenesis during evolution for advanced cancers. Our model provides a novel insight into the evolutionary role of NLS in oncogenic kinases in cancers.

KW - EGFR

KW - NLS

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85032574049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032574049&partnerID=8YFLogxK

U2 - 10.7150/jca.17961

DO - 10.7150/jca.17961

M3 - Article

VL - 8

SP - 903

EP - 912

JO - Journal of Cancer

JF - Journal of Cancer

SN - 1837-9664

IS - 5

M1 - 961

ER -